Depleting IFIT2 Enhances Oral Cancer Metastasis via Activation of aPKC and TNF Pathways

来源 :2016第九届世界癌症大会 | 被引量 : 0次 | 上传用户:beautyyin123
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Oral squamous cell carcinoma (OSCC) is the sixth most common cancer in the world.The major causes of OSCC-related death are cervical node and distant metastasis.
其他文献
EphA4 belongs to the largest family of receptor tyrosine kinases (RTKs).It is unknown whether EphA4-deleted microenvironment affects tumor progression.
会议
Human β-defensin-3 (hBD3) is an epithelial cell-derived innate immune regulatory molecule overexpressed in head neck cancer for tumor progression.Expression ofhBD3 is induced by the EGFR signaling.
会议
Non-coding RNAs,such as lncRNAs and miRNAs,play important role in human epithelial ovarian cancer (EOC) development and are involved in chemoresistance.
会议
Cytogenetic characterization of 27 dermatofibrosarcoma protuberans (DFSP) revealed clonal chromosome aberrations in all cases.One characteristic karyotypic feature in these tumors was a translocation
会议
Telomerase activation through the induction of its catalytic component TERT is essential in carcinogenesis.The regulatory mechanism and clinical significance underlying cancer-specific TERT expression
会议
In this study,we show that ectopic expression of microRNAmiR-196a enhances breast cancer cell proliferation while anti-miR-196a inhibits cell proliferationin vitro,and this is through the direct targe
会议
Beta-2-microglobulin (B2M) is a light chain subunit of the major histocompatibility complex (MHC) class Ⅰ complex and has been implicated in tumorigenesis.
会议
The investigation of reliable RNA based biomarkers requires the coordinate consideration of regulatory and target elements including microRNAs (miRNAs) and target genes.
会议
microRNAs (miRNAs) are important regulators of cancer stem cell (CSC) properties and are considered to be a potential therapeutic target.However,few studies have focused on miRNAs which are specifical
会议
The value of Circulating Tumor Cells in clinical practice is still in explorative stage but with promising expectations.CTCs are carrying the necessary features concerning the resistance of the diseas
会议